Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck

NCT01998542 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer of Head and Neck
Squamous Cell Carcinoma of the Head and Neck

Interventions

BIOLOGICAL: AlloVax
BIOLOGICAL: CRCL
BIOLOGICAL: AlloStim

Sponsor

Mirror Biologics, Inc.